Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter to the editor regarding conflicting reports of opaganib efficacy against high-fat diet-induced obesity.

Life sciences·2026
Same author

Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axis.

Nature communications·2026
Same author

Editor's Note: Cell Cycle-Dependent and Schedule-Dependent Antitumor Effects of Sorafenib Combined with Radiation.

Cancer research·2026
Same author

Reduction of TRAIL-Induced Mcl-1 and cIAP2 by c-Myc or Sorafenib Sensitizes Resistant Human Cancer Cells to TRAIL-Induced Death.

Cancer cell·2025
Same author

Three-stage hybrid spiking neural networks fine-tuning for speech enhancement.

Frontiers in neuroscience·2025
Same author

Opaganib Promotes Weight Loss and Suppresses High-Fat Diet-Induced Obesity and Glucose Intolerance.

Diabetes, metabolic syndrome and obesity : targets and therapy·2025

Related Experiment Video

Updated: Jun 16, 2026

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

Improved synthesis of a fluorogenic ceramidase substrate.

Zuping Xia1, Jeremiah M Draper, Charles D Smith

  • 1Department of Pharmaceutical and Biomedical Sciences, Medical University of South Carolina, MSC 140, Charleston, SC 29425, United States. xia@musc.edu

Bioorganic & Medicinal Chemistry
|January 21, 2010
PubMed
Summary

Researchers improved a method for synthesizing a key substrate used in ceramidase assays. This advancement facilitates the discovery of ceramidase inhibitors for hyperproliferative and inflammatory diseases.

More Related Videos

Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation
19:23

Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation

Published on: January 16, 2019

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
10:24

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources

Published on: January 27, 2026

Related Experiment Videos

Last Updated: Jun 16, 2026

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation
19:23

Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation

Published on: January 16, 2019

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
10:24

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources

Published on: January 27, 2026

Area of Science:

  • Biochemistry
  • Enzymology
  • Drug Discovery

Background:

  • Sphingolipid metabolizing enzymes, particularly ceramidases, are implicated in hyperproliferative and inflammatory diseases.
  • Ceramidases hydrolyze ceramide into sphingosine, a precursor to the mitogenic sphingosine 1-phosphate.
  • Development of ceramidase inhibitors is hindered by the lack of high-throughput screening assays.

Purpose of the Study:

  • To improve the synthesis of a fluorogenic ceramide analog for ceramidase assays.
  • To enable high-throughput screening for the identification of ceramidase inhibitors.

Main Methods:

  • Optimized the synthesis of a fluorogenic ceramide analog.
  • Incorporated hydroboration and Mitsunobu reactions.
  • Utilized triethylamine for improved acylation, increasing overall yield.

Main Results:

  • Achieved a fourfold increase in the overall yield of the ceramidase substrate.
  • Reduced the number of synthetic steps required.
  • Demonstrated the utility of the improved substrate in high-throughput screening assays for identifying ceramidase inhibitors.

Conclusions:

  • The enhanced synthesis of the fluorogenic ceramide analog significantly improves efficiency and yield.
  • This improved substrate is suitable for high-throughput screening.
  • The optimized method will accelerate the discovery of novel ceramidase inhibitors for therapeutic applications.